Patent: 6,042,824
✉ Email this page to a colleague
Summary for Patent: 6,042,824
Title: | Methods using cross linked protein crystal formulations as catalysts in organic solvents |
Abstract: | The present invention relates to the application of biocatalysis technology for performing selective chemical reactions. In one embodiment, this invention relates to crosslinked protein crystal formulations and their use as catalysts in chemical reactions involving organic solvents. This invention also provides methods for producing crosslinked protein crystal formulations and methods using them to optimize chemical reactions in organic solvents, including those used in industrial scale chemical processes. |
Inventor(s): | Khalaf; Nazer K. (Worcester, MA) |
Assignee: | Altus Biologics, Inc. (Cambridge, MA) |
Application Number: | 08/868,088 |
Patent Claims: | see list of patent claims |
Details for Patent 6,042,824
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2016-05-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |